Ulcerative colitis in children: medical management

Area of Science:

• Gastroenterology
• Pediatric Gastroenterology
• Immunology

Background:

• Ulcerative colitis (UC) is a chronic, relapsing inflammatory disorder of the colonic mucosa with unknown etiology.
• The inflammation typically affects a continuous segment of the bowel, starting in the rectum.
• Management aims to control symptoms and prevent disease flares due to the unknown cause.

Purpose of the Study:

• To review current therapeutic strategies for ulcerative colitis, particularly in pediatric patients.
• To discuss the role of various immunomodulators in managing pediatric ulcerative colitis.
• To highlight the comprehensive care needs of children with UC, including growth and development.

Main Methods:

• Review of existing literature on ulcerative colitis treatment.
• Analysis of therapeutic agents including 5-aminosalicylates, corticosteroids, and various immunomodulators.
• Consideration of surgical interventions like colectomy for refractory cases.

Main Results:

• 5-aminosalicylates and corticosteroids are primary treatments for ulcerative colitis.
• Immunomodulators (mercaptopurine, azathioprine, methotrexate, cyclosporine, tacrolimus) are increasingly used in pediatric UC.
• Colectomy is reserved for severe cases unresponsive to medical management.

Conclusions:

• Therapeutic strategies for ulcerative colitis focus on modulating inflammation to control symptoms and prevent relapses.
• Pediatric ulcerative colitis management requires balancing symptom control, growth, and development against treatment risks.
• The decision between long-term medical therapy and surgery involves careful risk-benefit assessment for children and adolescents.